Gonadotropin Hormone Therapy · Educational Resource

Understanding HCG and Fertility Hormone Research

HCG Fertility Hormone Research Philippines

Pharmacological Classification

Human chorionic gonadotropin (hCG), a glycoprotein hormone

Approved Clinical Applications

Hypogonadotropic hypogonadism and fertility protocol support

Administration Protocol

Subcutaneous injection, per physician-directed schedule

Want to learn more?

A licensed team will reach out to guide you through the research.

Book a consultation →

Gonadotropin Hormone Therapy · Educational Resource

Understanding HCG and Fertility Hormone Research

01 — Overview

What is HCG?

Human chorionic gonadotropin (HCG) is a glycoprotein hormone naturally produced during pregnancy, but is also manufactured as an FDA-approved medication used to support reproductive hormone function in both men and women.

To understand its clinical role, it helps to think of HCG as a stand-in for luteinizing hormone (LH), the pituitary signal that tells the gonads to produce sex hormones. When the body's own LH signal is insufficient, HCG can step in to activate the same downstream receptors.

Unlike compounded investigational peptides, HCG is a mass-manufactured, FDA-approved medication with established clinical indications, including hypogonadotropic hypogonadism and ovulation induction. It remains available strictly by prescription and requires monitoring by a licensed physician.

02 — How it works

How It Works: Luteinizing Hormone Receptor Activation

The primary mechanism researchers evaluate when studying HCG is its capacity to bind to and activate luteinizing hormone (LH) receptors in the testes and ovaries, closely mimicking the body's natural LH signal.

In men, this receptor activation stimulates Leydig cells to produce testosterone and supports spermatogenesis, which is why HCG is frequently studied as an adjunct therapy to help preserve testicular function and fertility during testosterone replacement protocols.

Administration Guidance

HCG is administered via subcutaneous injection, typically on a schedule determined by the specific approved indication, such as fertility support or adjunctive testosterone replacement therapy protocols. Dosing frequency and duration are determined exclusively by a licensed prescribing physician based on individual hormone panels and treatment goals.

03 — Areas of research

Summary of Investigated Research Areas

Ongoing clinical research continues to evaluate HCG across several physiological systems, particularly relating to testicular function preservation, ovulatory induction, and fertility protocol optimization.

Testicular Testosterone Preservation

Clinical trials evaluate HCG's role in maintaining intratesticular testosterone during exogenous testosterone therapy.

Spermatogenesis Support

Studies examine HCG's effect on sperm production in men with hypogonadotropic hypogonadism.

Ovulation Induction

Research evaluates HCG's use in triggering ovulation as part of assisted reproductive protocols.

Combination TRT Protocols

Investigations assess co-administration of HCG alongside testosterone therapy to mitigate testicular atrophy.

Luteinizing Hormone Receptor Studies

Comparative research examines HCG's structural similarity to LH and its receptor-binding affinity.

Pediatric Cryptorchidism Research

Historical and clinical literature evaluates HCG's role in testicular descent in prepubertal boys.

04 — FAQ

Frequently Asked Questions

05 — References

References and Academic Literature

Coviello, A. D., Matsumoto, A. M., Bremner, W. J., et al. (2005). Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.. Journal of Clinical Endocrinology & Metabolism, 90(5), 2595-2602.

Depenbusch, M., von Eckardstein, S., Simoni, M., & Nieschlag, E. (2002). Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.. European Journal of Endocrinology, 147(5), 617-624.

Practice Committee of the American Society for Reproductive Medicine. (2008). Gonadotropin preparations: past, present, and future perspectives.. Fertility and Sterility, 90(5 Suppl), S13-S20.

i

Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.

Getting started

How to Get Started?

Patient having a telehealth video consultation with a licensed doctor from home

1. Consult

Book a free consultation with our licensed healthcare team.

100 % online. Hassle-free. Convenient.

Friendly Philippine-licensed doctor standing and smiling, ready for your assessment

2. Real Human Assessment

Talk with Philippine-licensed doctors and get prescribed.

Always doctor-led—never just an online form.

Free consultation with licensed providers

Hand holding a Seenergie peptide program box, ready for doorstep delivery

3. Start your Program

Your medication is prepared and delivered to your doorstep.

No lock-ins. No hidden fees. No subscriptions.

Formulated in FDA-regulated pharmacies

Seenergie patient care agent wearing a headset, ready to assist on a call

4. Consistent care

Stay on track with regular weekly follow-ups. On your chosen communication platform.

Unlimited complementary follow-ups